Thrombologic ApS: Clinical Trials

2 trials sponsored by Thrombologic ApS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Completed 1

Follow Thrombologic ApS: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis
Ilomedin and Integrilin, low molecular weight heparin. - Pneumonia
Phase 2TerminatedThrombologic ApS52012-06-012016-04-22
Ilomedin Treatment for Patients Having Undergone Primary Percutaneous Coronary Intervention (PCI)
Ilomedin, Placebo, Ilomedin and standard low dose treatment - Myocardial Infarct
Phase 1 / Phase 2CompletedThrombologic ApS162010-09-012011-06-02

Conditions studied

Myocardial Infarction (1)  ·  Pneumonia (1)

Interventions

Eptifibatide (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Iloprost (1)  ·  Therapeutics (1)

Countries

Denmark (2)  ·  Finland (1)

Top investigators

Lene Holmvang, MD (1)

Results publications

PMID 22951358